Silver Bullet brings the world’s first regulatory- approved antimicrobial bone screws into orthopedics

Website - Silver Bullet Therapeutics Silver Bullet Therapeutics Secures CE Mark Approval for Revolutionary New Antimicrobial Bone Screw System (press release) Expanded CE Mark Positions Silver Bullet to Improve Patient Care in the EU and Disrupt Established Commercial Trauma Market Silver Bullet Therapeutics, Inc., a privately-held medical device company, announced today that it has received recommendation for CE Mark approval for the commercial sale of its antimicrobial OrthoFuzIon Bone Screw System in the European Union for orthopedic reduction and internal fixation procedures anywhere in the body. Over the next few months, Silver Bullet will be finalizing launch plans with its prospective partners for selected European markets. The OrthoFuzIon Orthopedic Bone Screw System is the world’s first regulatory- approved antimicrobial bone screw product for orthopedic procedures. The OrthoFuzIon System expands upon the previously approved cannulated screw system and now includes both solid and cannulated titanium bone screws. Bone screws are coated with the Silver Bullet Therapeutics proprietary coating, called AntiBacterIon, to facilitate sustained silver ion release. The AntiBacter...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top